MyFinsight
Home
Blog
About
Back
Income Statement
Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. (ACXP)
source: myfinsight.com
Net loss
-$2,254,173
(-0.35%↓ Y/Y)
Interest income
$53,055
(126.69%↑ Y/Y)
Operating loss
-$2,307,228
(-1.65%↓ Y/Y)
Total operating
expenses
$2,307,228
(1.65%↑ Y/Y)
General and
administrative
$1,235,692
(-29.21%↓ Y/Y)
Research and development
$1,071,536
(104.41%↑ Y/Y)
Back